Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry - GuruFocus.com
Submitted by Anonymous (not verified) on Thu, 07/07/2022 - 12:55
